Skip to main content
PolicySpeak
← All files
FT

Fondazione Telethon

NGO · Italy · EU Transparency Register 600735639422-31

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 784 non-governmental organisations on this site, they rank #608 by legislative files engaged — a count of participation, not a measure of influence.

0.4
declared lobbying FTE
self-declared
€25K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2020
in the register since

Declares membership of

  • Fondazione Telethon is member of:
  • IRDiRC (https://irdirc.org/)
  • ICPerMed (https://www.icpermed.eu/)
  • ARM (https://alliancerm.org/)
  • Treat-NMD (https://treat-nmd.org/)
  • ENMC (https://www.enmc.org/)

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Non-governmental organisations
Registered as
Fondazione Telethon ETS (FTELE)
Head office
Roma, Italy
EU office
Milan

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Fondazione in PolicySpeak: request access →

Work at Fondazione Telethon? so we know who speaks for it.

Follow the file Fondazione Telethon engages with

One email on Tuesdays when a new position is filed on this file, from Fondazione Telethon or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Fondazione Telethon filed 1 position on 11 Jun 2025, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.

What they argued

European Biotech Actfiled 11 Jun 2025PDFsource

Fondazione Telethon welcomes the EC’s initiative to create an enabling environment to accelerate the transition of biotech products from laboratory to the market. As the first charity holder of a marketing authorisation (MA) in the EU for a medicinal product targeting an ultra-rare disease, Fondazione Telethon suggests that the scope of this initiative is broadened also to non-profit entities engaged in the…

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Fondazione Telethon’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.